drugset / Trial / NCT01473563

A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC)

NCT01473563 ↗

Phase 2 Completed 52 enrolled Eli Lilly and Company
NaSingle-groupOpen-label

Summary

The main purpose for this study is to answer the following research questions: * Can pemetrexed be administered safely at the participant's home, using the same treatment procedure as in a hospital setting? * Will the participant be satisfied with home care? * How might this impact the participant's quality of life? * What are the required medical resources needed to give pemetrexed in a home setting?

Timeline

Start
2011-12
Primary completion
2013-09
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Pemetrexed Small molecule 500 mg/m2 Intravenous